Showing results (311-320 of 971) with videos related to

Sort By:
Pageof 98
BMJ Open|November 27, 2020
Cost-effectiveness analysis of adding ramucirumab to the first-line erlotinib treatment for untreated EGFR-mutated metastatic non-small cell lung cancer in ChinaQiao Liu, Xia Luo, Liubao Peng, et al.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology|October 3, 2015
[Single chain antibody against β-site of amyloid precursor protein inhibits the generation of β-amyloid peptide]Wei Huang, Lirong Zhou, Xiaoou Li, et al.
BMC Infectious Diseases|March 8, 2018
Factors affecting time to sputum culture conversion and treatment outcome of patients with multidrug-resistant tuberculosis in ChinaQiao Liu, Peng Lu, Leonardo Martinez, et al.
Molecules (Basel, Switzerland)|May 13, 2018
Anti-Inflammatory Triterpenoids from the <i>Caulophyllum robustum</i> Maximin LPS-Stimulated RAW264.7 CellsBin-Hua Qin, Xin-Qiao Liu, Qiao-Yu Yuan, et al.
Zhonghua Yi Xue Za Zhi|February 9, 2010
[Effect of lung stress index upon titration of positive end-expiratory pressure at post-recruitment in patients with acute respiratory distress syndrome]Ying-Zi Huang, Yi Yang, Song-Qiao Liu, et al.
The Journal of Nutrition, Health & Aging|November 26, 2025
Comparison of Seven Sarcopenia Screening Tools in Older Type 2 Diabetes Patients Using Four Diagnostic CriteriaQiao Liu, Miaomiao Wang, Qiaoling Yang, et al.
Computational and Structural Biotechnology Journal|January 16, 2026
AOP-DRL: A deep representation learning framework for the computational prediction of antioxidant peptidesYongzhu Zhou, Wanlin Liu, Qiao Liu, et al.
Frontiers in Bioengineering and Biotechnology|July 17, 2025
High-accuracy lung sound classification for healthy versus unhealthy diagnosis using artificial neural networkWeiwei Zhang, Xinyu Li, Qiao Liu, et al.
BMC Cancer|October 16, 2025
Analysis of FNDC1 as a diagnostic marker and potential therapeutic target for ovarian serous cancerHongying Jiao, Jing Tian, Qiao Liu, et al.
Risk Management and Healthcare Policy|April 17, 2024
Cost-Effectiveness of First-Line Atezolizumab versus Chemotherapy in Non-Small-Cell Lung Cancer Patients Ineligible for Platinum-Containing RegimensLan-Fang Li, Ran Qi, Tian-Tian Wei, et al.
Pageof 98